Tuesday, February 14, 2012

ALS MND Daily News Digest

The ALS Therapy Development Institute to Launch Phase II Clinical Trial of TDI ...
MarketWatch (press release)
About ALS Therapy Development Institute ( www.als.net ) The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) as soon as possible ...
See all stories on this topic »
Concussion In Contact Sports (VIDEO)
Huffington Post
At the age of 34, he is also living with a debilitating disease, amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease. And he's not alone. A recent story in Scientific American profiles Kevin Turner, called "the collision expert," ...
See all stories on this topic »

No comments:

Post a Comment